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A BSTRACT 
Background: Control of pulmonary TB is getting more and more complicated as the 
number of patients with diabetes mellitus (DM) is increasing. The increasing prevalence of 
DM is followed by the increasing prevalence of pulmonary TB. Diabetes Mellitus patients 
have 4,7 times higher risk to develop pulmonary TB compared to patients without DM, 
since DM can increase the frequency and severity of an infection, including pulmonary TB. 
Aim: To analyze macrophage activity (phagocytosis, intracellular killing, and TNF-α 
synthesis) of TB-DM patients. 
Method: The research was an experimental study used a PBMC cultured sample from TB-
DM patient's which undergo observation of macrophage activity (phagocytic, intracellular 
killing and TNF-α synthesis). The data were taken from microscopic observation of TB-
DM patients, colony growth of viable Mycobacterium tuberculosis and the TNF-α level 
secreted by macrophages. 
Result: Microscopic observation showed that there wereless amount of phagocytosed M. 
tuberculosis (in macrophage/intracellular level) and there was a little amount of formed 
vacuoles and giant cells. Furthermore, macrophages in TB-DM patients secrete low level of 
TNF-α, and there were more viable M. tuberculosis from this macrophage. 
Conclusions: Macrophages of TB-DM patients are less activated, with reduced phagocytic 
activity toward M. tuberculosis.. 
Keywords: macrophage, TB-DM, phagocytosis, intracellular killing, TNF- α. 
 
INTRODUCTION 
Tuberculosis (TB) is a major cause of death 
among bacterial infection diseases. TB affects 9,4 
million people and kills 1,7 million of world 
population annually. The etiology is 
Mycobacterium tuberculosis bacteria which has a 
rod shape, aerobe characteristic, and acid-fast 
feature. Indonesia rank 4th worldwide for its high 
number of TB patients 1,2,3  World Health 
Organization expects that TB control will become 
more difficult with the increasing number of 
diabetes mellitus (DM) patients, due to DM is one 
of the risk factors for TB deterioration. 
 
 
Correlation between TB and DM have been 
reported since 1000 AD, though it is still  difficult 
 
to be defined.4,5,6The increasing cases of TB-DM 
are associated with an increase in morbidity and 
mortality of TB and DM. DM patients have4,7 times 
higher risk to develop pulmonary TB.4 This is due 
to the treatment of MDR-DM cases, which one of 
its aim is to restore the function of the immune 
system, i.e. immunostimulant.7 Less activated 
alveolar macrophage of pulmonary TB patients 
with DM reduces the interaction between T 
lymphocyte and macrophage, resulting in defect of 
M. tuberculosis elimination. 
 
17  
 
Journal of Biomedicine and Translational Research 02 (2016) 16 - 21
The entry of M. tuberculosis into the 
macrophage and its ability to survive are the key 
lement of the pathogenesis of tuberculosis.8,9 On 
primary infection, aerosol droplet nuclei containing 
M.
ng M. 
tub
mononuclear cells (PBMC) of 
TB
e a history of DM and have a 
blood pressure more than 140/90mmHg. TB 
recruited from the hospitals patients 
tha
ersity. 
s much as 20mL of peripheral blood was 
t HI-PHS/Heat Inactivated Pooled 
Hu
of platinum (10  CFU/mL) of M. 
tuberculosis H37Rv ATCC 27294T (signal) strain 
ory, 
Tro
was added by 106 CFU/mL suspension of 
 
27
e
 tuberculosis is inhaled and settle on the 
pulmonary alveolar epithelial cell surface 
expressing adhesion molecule (intracellular 
adhesion molecule-1/ICAM-1), thereby increasing 
the migration and adhesion of phagocytic cells, 
particularly alveolar macrophage which effectively 
phagocyte all particles including M. 
tuberculosis.9,10 Immune response by macrophage 
in the form of phagocytosis and intracellular killing 
which contributes to the immune defense is 
expected to be the first in line to eliminate M. 
tuberculosis and lower the incidence of TB. 
However, M. tuberculosisis able to multiply within 
macrophage thereby causing tuberculosis. 
The increase in cases of TB-DM that associated 
with the increased of morbidity and mortality due 
to TB-DM, which is DM patients have an immune 
respond disorder, thereby facilitati
erculosis infection. Thus, it is important to 
know more about the treatment of cases of TB-
DM, one of which emphasizes the restoration of 
immune abnormalities. Therefore, to be able to 
find out, it is necessary to do the initial research 
with emphasis on the activity of macrophages from 
TB-DM patients.  
This study is aimed to analyze macrophage 
activity (phagocytic, intracellular killing and TNF-
α synthesis) from TB-DM patients, by identifying 
peripheral blood 
-DM patients. 
 
METHODS 
DM patients were obtained from the TB 
patients who hav
patients were 
t have BTA (+) and chest X-ray (+).  Healthy 
individu were the individu who have BTA (-) and 
chest X-ray (-). There were 18 samples of DM 
patients, TB patients, and healthy individu were 
recruited for this study, and all of the samples was 
signed the informed consents. 
Ethical clearance was provided by Gadjah 
Mada University (EC numb. 36/EC/2.08.16). Most 
of the laboratory works were performed in Faculty 
of Medicine GadjahMada Univ
 
PBMC’s Isolation (Peripheral Blood 
Mononuclear Cells) 
A
taken from TB-DM patients and continued with 
defibrination.  
Ten milliliters of RPMI1640 medium (Sigma-
Aldrich Inc., R0883)were added (RPMI 1640 
medium withou
man Serum supplementation), then each 5mL 
were moved into a tube containing 3mL Ficoll-
Histopaque (Sigma-Aldrich Inc., 10771), then 
centrifuged.12,13,14 Supernatant layer was discarded, 
the pellet was rinsed and added with 4000 µl RPMI 
1640 (+) medium (heated RPMI 1640 medium 
supplemented with 10% inactivated human serum 
with 56°C for 30 minutes/HI-PHS/Heat Inactivated 
Pooled Human Serum), and then continued by mix 
pipetting. Monocyte viability was determined using 
tryphan blue exclusion (≥95%).16 Monocyte 
percentage was determined using Giemsa stain on 
the smear of centrifuge result. Monocyte (105/mL) 
were cultured in a 24-wells tissue culture plate 
covered by coverslip and then it was added with 
RMPI 1640 medium, 7,2 pH, contains 25mM 
HEPES and L-glutamine without serum and 
antibiotic.16 
 
Opsonization of Mycobacterium tuberculosis 
An ose 6
(derived from cultures of tuberculosis laborat
pical Disease Centre Institute, Airlangga 
University)were inserted aseptically into screw cap 
tube containing 4000µL of Middlebrook 7H9 
liquid medium and ± 6 -7 bead glass and 
homogenous vortex, then 4000 µL suspension was 
added and centrifuged. Supernatant was discarded, 
the pellet was set aside and rinsed with 5000 µl 
sterile PBS for 3 times. Pellet again was set aside 
and 4000µl RPMI 1640 (-) medium and 4000µl 
PHS/Pooled Human Serum were added. Next step 
is suction spray approximately 10 times with 26G 
tuberculin syringe and incubated at 37°C 
containing 5% CO2for 20 minutes then centrifuged. 
The supernatant layer was discarded, the pellet was 
rinsed with 5000mL of sterile PBS for 3 times, 
then 4000mL RPMI 1640 medium (+) were added. 
 
Co-Culture of Macrophage and M. tuberculosis 
On the 7th day, the macrophage cells culture 
opsonized-M. tuberculosis strain H37Rv ATCC
294T, and then it was incubated at 37°C with air 
containing 5% CO2for 24 hours, 48 hours, 7 times 
24 hours and 14 times 24 hours.13,15,17 
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Macrophage Activity Tests and TNF-α Levels 
Measurement 
Coverslip on the base of a 24-wells tissue culture 
kit (88-7346-76, Ready-SET-
Go
g, 200µL were taken 
an
 7H
 CO2 level for 7 days, 10 days, and 
14
hich 
can still grow on solid Middlebrook 7H10 agar 
as CFU/ml of the  7th, 10th, 
an
came from the result of the 
macrophage microscopic observation of the TB-
viable M. tuberculosis colony 
gro
e mononuclear 
cells in the buffy coat layer from the peripheral 
the TB-DM patients consists of 
mo
 
Figure 1.Macrophages of TB-DM patients ingested 
M. tuberculosis (NIKON Eclipse E600 light 
microscope, magnification of 1700X). 
and healthy 
dividuals can be seen in Table 2.  
ndividu can be 
see
-20% buffy coat is consisted 
of monocytes, the rest were lymphocytes.19 Buffy 
etween the upper layer (plasma) 
and
a to 
inv
plate was aseptically rinsed with sterile PBS for 5 
times.  
Sixty µl supernatant was taken from 24-well 
tissue culture plate aseptically, then test by used an 
ELISA 
!,eBioscience, DTA00C). TNF-α levels was 
measured by ELISA reader.  
Coverslip base of a 24-well tissue culture plate 
was scraped to harvest the macrophage, then 
shaken well by mix pipettin
d transferred into eppendorf tubes. An 800mL 
sterile PBS were added and centrifuged. 
Supernatant layer was discarded, the pellet was set 
aside, added with 1000mL of sterile distilled water, 
incubated for 30 minutes at 4°C and then vortex 
for 5 minutes macrophage are lysis and 
intracellular M. tuberculosis free from 
macrophage. 
Thirty µl was taken from, dropped on a solid 
Middlebrook 10 agar medium, and incubated at 
37OC with 5%
 days to determine the number of bacteria 
surviving, not digested by macrophages; with 
counting colonies grown per ml (CFU / ml).18 
 
CFU Measurement 
The number of M. tuberculosis colonies w
medium are counted 
d 14th day. 
 
Data Analysis 
The data 
DM patients, 
wth, and the TNF-α levels secreted by 
macrophages by used statistic test.  
 
RESULTS 
The study results showed that th
blood of 
nocytes and lymphocytes. Monocytes of TB-
DM patients which have matured into 
macrophages within 7 days were co-cultured with 
M. tuberculosis (in vitro). The results of 
microscopic observation from macrophages of TB-
DM patients showed that there is less number of 
ingested M. tuberculosis(red) and less formation of 
vacuoles and giant cell macrophages (blue) ) 
(Figure 1).  
 
TNF-α levels secreted by macrophages of TB-
DM patients, TB patients non-DM, 
in
Based on Table 2, the average levels of TNF-α 
secreted by macrophages of TB-DM patients, TB 
patients without DM, and healthy i
n as shown in Figure 2 . 
Average of viable M. tuberculosis colonies 
calculated as CFU/ml on day 7th, 10th, and 14thcan 
be seen in Figure 3. 
 
DISCUSSIONS 
Approximately 10
coat is located b
 the bottom layer (erythrocytes and 
granulocytes sediment) from PBMCs of TB-DM 
patients, consisting monocytes and lymphocytes. 
TB-DM patients’ monocytes which had matured 
into macrophages within 7 days appears as large 
rounded cells with regularly spherical nucleus 
resembling kidney/horseshoe (horseshoe-shaped), 
have cell wall protrusions and large cytoplasm, and 
also macrophages showing some presence of giant 
cells. While lymphocytes appeared as having large 
nuclei, round shape, heterochromatin features with 
a large nucleus-cytoplasm ratio.11,12,19,20 This study 
eliminated the presence of the lymphocytes using 
the PBS rinsing method in order to avoid the bias 
results from the process of intracellular killing 
because the lymphocytes have a role in producing 
IFN-γ as a mediator of macrophage activation. 
Additionally, this study carried out co-culture 
between macrophages and M. tuberculosis (in 
vitro). This was intended to provide the bacteri
ade macrophages in order to allow the 
phagocytosis process to take place. M. tuberculosis 
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ranes of 
ma
ages are also 
mo
 immune cells, the 
ma
-diabetic TB 
pa
ing M. 
tub
 
tha
oduce 
lip
CO LUSIONS 
f TB-DM patients are less 
act
invasion process in macrophages can take place 
after an opsonization21,22followed by binding and 
uptake of the complement receptors (CR1, CR3, 
and CR4),21,23 mannose receptor, surfactant, and 
Toll-Like Receptors (TLR). The interaction 
between opsonized M. tuberculosis with 
macrophages membranes can lead to ingestion/ 
engulfment and metabolic burst, which 
characterized by an increase in oxygen 
consumption (O2), production of superoxide anion 
(O2-), and hydrogen peroxide (H2O2). 
The process of ingestion/ engulfment begins 
with the introduction of M. tuberculosis by 
macrophages receptors, memb
crophages will surround the bacteria in a circle 
(zipper mechanism), thus the bacteria are in the 
phagosome.21Phagosome then undergoes 
maturation and then fuse with lysosomes to form 
phagolysosome,21 an organelle with antimicrobial 
component and acidic pH (pH ~ 6,2). 
Macrophages from the activated TB patients are 
more effective in performing the phagosome and 
lysosome fusion. In addition, macroph
re effective in producing oxygen radicals, NO, 
and various antimicrobial molecules26-28and may 
increase respiratory burst, ROI production, RNI, 
and TNF-α releasing.29,30 
Macrophages of TB-DM patients are activated 
macrophages, but because the TB-DM patients 
have defects in their
crophages become less activated. Furthermore, 
macrophages in DM patients have disruption of 
chemotaxis, phagocytosis, and antigen presenting 
phagocytes against M. tuberculosis. This defect 
cannot be resolved with insulin therapy.14 Patients 
with poorly controlled DM will upset the 
phagocytosis, especially if it has been in an 
acidosis state. This phagocytosis disruption is due 
to the intrinsic defect of the PMN.12 
This results showed that there were decreased 
production of TNF-α in pulmonary tuberculosis 
patients with DM rather than non
tients. It is according to the literature mentioned 
that Th-1 response levels, IFN-γ, as well as the 
production of IL-1 β and IL-6 are more profound 
in pulmonary tuberculosis patients with DM rather 
than non-diabetic  TB patients. Decreased 
production of IFN-γ was more significant in 
patients with pulmonary tuberculosis with 
uncontrolled diabetes than in patients with 
controlled DM TB. This IFN-γ production will 
return to normal within six months, either in 
patients with pulmonary TB alone or pulmonary 
TB patients with uncontrolled DM, but will 
continue to decline in pulmonary TB patients with 
uncontrolled DM. Also, there were changes in 
pulmonary vascular and alveolar oxygen tension 
that aggravated the patients’ condition.4,23,33 
TNF-α proved to be effective in eliminat
erculosis, this cytokine will increase the 
phagocytosis capability and induces apoptosis of 
infected macrophages. Both TNF-α and IFN-γ will 
increase the intracellular killing macrophages 
process by producing reactive NO. TNF-α also 
plays a role in maintaining granuloma integrity, 
which formed when macrophages infected by M. 
tuberculosis. Macrophages that are unable or only 
slightly expresses TNF-α would be very easily 
infected and difficult to eliminate M. tuberculosis. 
The presence of viable M. tuberculosis showed
t this bacteria is able to escape and survive the 
macrophage phagocytosis and intracellular killing 
macrophage. Immune cell defects, fewer 
macrophages activation, and decreased in 
phagocytic capability in patients with TB-DM can 
support the viability of M. tuberculosis. In 
accordance with these results, it is known that there 
are more viable M. tuberculosis in TB-DM 
patients’ macrophages as shown in Figure 3. 
M. tuberculosis can also pr
oarabinomannan (LAM), which can inhibit the 
activation of macrophages and is an important 
virulence determinant of these bacteria. LAM can 
inhibit the functions induced IFN-γ thus disrupts 
the microbicidal function of macrophages, 
inhibiting the activity of protein kinase C, and 
TNF-α evocation.34 
 
NC
Macrophages o
ivated macrophages, where there are 
disturbances in its phagocytosis capability (due to 
the intrinsic defect of the PMN) and its phagocytes 
antigen presenting toward M. tuberculosis. These 
are shown in the results, that the TB-DM 
macrophages secreted low levels of TNF-α and 
there are more numbers of viable M. tuberculosis. 
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Table 2. TNF-α levels secreted by macrophages of TB-DM patients, TB patients without DM, and healthy individu 
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Healthy individu
Viable Mycobacterium 
tuberculosis (CFU/ml) Day 
7th
Viable Mycobacterium 
tuberculosis (CFU/ml) Day 
10th
Viable Mycobacterium 
tuberculosis (CFU/ml) Day 
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TNF-α 
 
TB-DM patients TB patients without DM  
 
Healthy Individu 
(pg/ml) (pg/ml) (pg/ml) 
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
78 97 81 103 91 81 101 132 98 111 123 132 89 103 86 127 99 101 
86 98 97 87 75 103 111 143 117 97 121 98 98 107 98 113 97 97 
93 89 101 81 97 97 96 118 81 134 117 131 100 97 99 136 103 131 
Table 3.Mean and  standard deviation of TNF-α levels secreted by macrophages of TB-DM patients, TB 
patients without DM, and healthy individu 
 
Mean 
SD 
 
TB-DM patients TB patients without DM  
 
Healthy Individu 
(pg/ml) (pg/ml) (pg/ml) 
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
41.2 
2.2 
48.1 
2.3 
43.6 
2.5 
44.1 
2.7 
41.5 
2.1 
48.1 
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45.1 
2.0 
46.7 
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2.1 
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2.1 
42.6 
2.4 
49.1 
2.6 
47.6 
2.4 
46.5 
2.1 
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2.7 
41.3 
2.3 
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41.3 
2.4 
48.3 
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2.1 
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43.6 
2.5 
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42.6 
2.4 
47.6 
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47.6 
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Figure 2. Average of TNF-α levels secreted by macrophages of TB-DM patients, TB patients non-DM, and healthy 
individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Average number of viable M. tuberculosis colonies (CFU / ml).  
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